APA

Hughes D. A., Nicholls K., Shankar S. P., Sunder-Plassmann G., Koeller D., Nedd K., Vockley G., Hamazaki T., Lachmann R., Ohashi T., Olivotto I., Sakai N., Deegan P., Dimmock D., Eyskens F., Germain D. P., Goker-Alpan O., Hachulla E., Jovanovic A., Lourenco C. M., Narita I., Thomas M., Wilcox W. R., Bichet D. G., Schiffmann R., Ludington E., Viereck C., Kirk J., Yu J., Johnson F., Boudes P., Benjamin E. R., Lockhart D. J., Barlow C., Skuban N., Castelli J. P., Barth J. & Feldt-Rasmussen U. (20171103). Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. : Journal of medical genetics.

Chicago

Hughes Derralynn A, Nicholls Kathleen, Shankar Suma P, Sunder-Plassmann Gere, Koeller David, Nedd Khan, Vockley Gerard, Hamazaki Takashi, Lachmann Robin, Ohashi Toya, Olivotto Iacopo, Sakai Norio, Deegan Patrick, Dimmock David, Eyskens François, Germain Dominique P, Goker-Alpan Ozlem, Hachulla Eric, Jovanovic Ana, Lourenco Charles M, Narita Ichiei, Thomas Mark, Wilcox William R, Bichet Daniel G, Schiffmann Raphael, Ludington Elizabeth, Viereck Christopher, Kirk John, Yu Julie, Johnson Franklin, Boudes Pol, Benjamin Elfrida R, Lockhart David J, Barlow Carrolee, Skuban Nina, Castelli Jeffrey P, Barth Jay and Feldt-Rasmussen Ulla. 20171103. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. : Journal of medical genetics.

Harvard

Hughes D. A., Nicholls K., Shankar S. P., Sunder-Plassmann G., Koeller D., Nedd K., Vockley G., Hamazaki T., Lachmann R., Ohashi T., Olivotto I., Sakai N., Deegan P., Dimmock D., Eyskens F., Germain D. P., Goker-Alpan O., Hachulla E., Jovanovic A., Lourenco C. M., Narita I., Thomas M., Wilcox W. R., Bichet D. G., Schiffmann R., Ludington E., Viereck C., Kirk J., Yu J., Johnson F., Boudes P., Benjamin E. R., Lockhart D. J., Barlow C., Skuban N., Castelli J. P., Barth J. and Feldt-Rasmussen U. (20171103). Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. : Journal of medical genetics.

MLA

Hughes Derralynn A, Nicholls Kathleen, Shankar Suma P, Sunder-Plassmann Gere, Koeller David, Nedd Khan, Vockley Gerard, Hamazaki Takashi, Lachmann Robin, Ohashi Toya, Olivotto Iacopo, Sakai Norio, Deegan Patrick, Dimmock David, Eyskens François, Germain Dominique P, Goker-Alpan Ozlem, Hachulla Eric, Jovanovic Ana, Lourenco Charles M, Narita Ichiei, Thomas Mark, Wilcox William R, Bichet Daniel G, Schiffmann Raphael, Ludington Elizabeth, Viereck Christopher, Kirk John, Yu Julie, Johnson Franklin, Boudes Pol, Benjamin Elfrida R, Lockhart David J, Barlow Carrolee, Skuban Nina, Castelli Jeffrey P, Barth Jay and Feldt-Rasmussen Ulla. Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study. : Journal of medical genetics. 20171103.